Association of PAX5 Expression with Clinical Outcome in Patients with TaT1 Transitional Cell Carcinoma of the Bladder

Babjuk, M. - Soukup, V. - Mareš, J. - Dušková, J. - Pecen, Ladislav - Pešl, M. - Pavlík, I. - Dvořáček, J.
Association of PAX5 Expression with Clinical Outcome in Patients with TaT1 Transitional Cell Carcinoma of the Bladder.
Urology. Roč. 67, č. 4 (2006), s. 756-761. ISSN 0090-4295. E-ISSN 1527-9995
Impakt faktor: 2.130, rok: 2006
http://hdl.handle.net/11104/0150678

Citováno: 11

--- FELDMAN, A.L. - DOGAN, A. Diagnostic uses of Pax5 immunohistochemistry. ADVANCES IN ANATOMIC PATHOLOGY. ISSN 1072-4109, SEP 2007, vol. 14, no. 5, p. 323-334. [WOS]
--- TZANKOV, A.S. - WENT, P.T. - MUNST, S. - PAPADOPOULOS, T. - JUNDT, G. - DIRNHOFER, S.R. Rare expression of BSAP (PAX-5) in mature T-cell lymphomas. MODERN PATHOLOGY. ISSN 0893-3952, JUN 2007, vol. 20, no. 6, p. 632-637. [WOS]
--- MORGENSTERN, D.A. - HASAN, F. - GIBSON, S. - WINYARD, P. - SEBIRE, N.J. - ANDERSON, J. PAX5 Expression in Nonhematopoietic Tissues. AMERICAN JOURNAL OF CLINICAL PATHOLOGY. ISSN 0002-9173, MAR 2010, vol. 133, no. 3, p. 407-415. [WOS]
--- ELTZE, E. - WILD, P.J. - WULFING, C. - ZWARTHOFF, E.C. - BURGER, M. - STOEHR, R. - KORSCHING, E. - HARTMANN, A. Expression of the Endothelin Axis in Noninvasive and Superficially Invasive Bladder Cancer: Relation to Clinicopathologic and Molecular Prognostic Parameters. EUROPEAN UROLOGY. ISSN 0302-2838, NOV 2009, vol. 56, no. 5, p. 837-845. [WOS]
--- YAN, M.Y. - HIMOUDI, N. - PULE, M. - SEBIRE, N. - POON, E. - BLAIR, A. - WILLIAMS, O. - ANDERSON, J. Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy. CANCER RESEARCH. ISSN 0008-5472, OCT 1 2008, vol. 68, no. 19, p. 8058-8065. [WOS]
--- DENZINGER, S. - BURGER, M. - HAMMERSCHMIED, C.G. - WIELAND, W.F. - HARTMANN, A. - OBERMANN, E.C. - STOEHR, R. Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome. PATHOLOGY. ISSN 0031-3025, 2008, vol. 40, no. 5, p. 465-469. [WOS]
--- DONG, B.W. - ZHANG, W.B. - QI, S.M. - YAN, C.Y. - GAO, J. Transactivation of PTGS2 by PAX5 signaling potentiates cisplatin resistance in muscle-invasive bladder cancer cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. ISSN 0006-291X, SEP 18 2018, vol. 503, no. 4, p. 2293-2300. [WOS]
--- HAO, L. - SHI, Z.D. - PANG, K. - HE, H.G. - ZHOU, R.S. - PANG, H. - ZHANG, J.J. - LIU, D.C. - SUN, Z. - HAN, C.H. The antitumor effect of the novel cancer-specific adenovirus Ad-VEGFR on bladder cancer in vitro and in vivo. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. ISSN 1936-2625, 2018, vol. 11, no. 10, p. 4795-4805. [WOS]
--- BHARTI, B. - MISHRA, R. Spleen-specific isoforms of Pax5 and Ataxin-7 as potential proteomic markers of lymphoma-affected spleen. MOLECULAR AND CELLULAR BIOCHEMISTRY. ISSN 0300-8177, APR 2015, vol. 402, no. 1-2, p. 181-191. [WOS]
--- CHENG, L. - DAVISON, D.D. - ADAMS, J. - LOPEZ-BELTRAN, A. - WANG, L.S. - MONTIRONI, R. - ZHANG, S.B. Biomarkers in bladder cancer: Translational and clinical implications. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. ISSN 1040-8428, JAN 2014, vol. 89, no. 1, p. 73-111. [WOS]
--- AGOSTINELLI, C. - SABATTINI, E. - GJORRET, J.O. - RIGHI, S. - ROSSI, M. - MANCINI, M. - PICCALUGA, P.P. - BACCI, F. - MARAFIOTI, T. - BETTINI, G. - FALINI, B. - PILERI, S.A. Characterization of a New Monoclonal Antibody Against PAX5/BASP in 1525 Paraffin-embedded Human and Animal Tissue Samples. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. ISSN 1541-2016, DEC 2010, vol. 18, no. 6, p. 561-572. [WOS]